Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Screening Young Children for Lead Poisoning: Guidance for State and Local Public Health Officials

Centers for Disease Control and Prevention (CDC)

Note: This document refers to various blood-lead thresholds and levels of concern for adverse health outcomes in children. This terminology is outdated and readers are referred to the ACCLPP recommendations of 2012.

Cover

November 3, 1997

February 21, 1997

NOTE: To obtain a printed copy of the screening document, please call (toll-free) 800-CDC-INFO (800-232-4636).

Document SectionsNo. of
Pages		Files
(Adobe Acrobat
PDF & GIF)
Cover page1cover.pdf [89 KB]
 
Title page2title.pdf [33 KB]
 
Contents
List of Tables and Figures		3contents.pdf [121 KB]
Forward2forward.pdf [64 KB]
Preface (pages 1-3)
Advisory Committee on Childhood Lead Poisoning Prevention (pages 4-8)
Executive Summary (pages 9-12)		12p1_12.pdf [157 KB]
Chapter 1. Childhood Lead Poisoning in the United States (pages 13-20)8chapter1.pdf [162 KB]
 
Chapter 2. A Comprehensive Approach to Childhood Lead Poisoning Prevention (pages 21-30)10chapter2.pdf [170 KB]
 
Chapter 3. The Statewide Plan for Childhood Blood Lead Screening (pages 31-76)46chapter3.pdf [299 KB]
Chapter 4. Role of Child Health-Care Providers in Childhood Lead Poisoning Prevention (pages 77-110)34chapter4.pdf [199 KB]
Chapter 5. CDC Resources and Information for Implementation of Guidance (pages 111-114)4chapter5.pdf [192 KB]
Chapter 6. Childhood Lead Poisoning Prevention Research Priorities (pages 115-116)2chapter6.pdf [60 KB]
Glossary (pages 117-121)5glossary.pdf [67 KB]
Appendix B.1 Blood Lead Levels in the United States. 1991-1994.

CDC. Update: Blood Lead Levels -- United States, 1991-1994. MMWR 1997; 46(7):141-146.

6
Appendix B.2 Blood Lead Levels in the U.S. Population.

Brody DJ, Pirkle JL, Kramer RA, et al. Blood lead levels in the U.S. population. JAMA 1994; 272(4): 277-283.

8jama277.gif [100 KB]
jama278.gif [112 KB]
jama279.gif [112 KB]
jama280.gif [78 KB]
jama281.gif [107 KB]
jama282.gif [75 KB]
jama283.gif [117 KB]
Appendix B.3 The Decline in Blood Lead Levels in the United States.

Brody DJ, Pirkle JL, Gunter EW, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES III). JAMA 1994; 272(4): 284-291.

8jama284.gif [110 KB]
jama285.gif [105 KB]
jama286.gif [95 KB]
jama287.gif [111 KB]
jama288.gif [9 3KB]
jama289.gif [117 KB]
jama290.gif [104 KB]
jama291.gif [90 KB]
Appendix B.4 Costs and Benefits of a Universal Screening Program for Elevated Blood Lead Levels in 1-Year-Old Children19b4.pdf [85 KB]
Appendix B.5 Relationship Between Prevalence of BLLs >=10 µg/dL and Prevalences Above Other Cut-Off Levels2b5.pdf [25 KB]
Appendix B.6 Exact Confidence Intervals for Some Hypothetical Estimates of Prevalence of BLLs >=10 µg/dL, by Number of Children Screened2b6.pdf [10KB]
Appendix B.7 Conditions Required for a Source of Lead to be a Hazard1b7.pdf [9 KB]
Appendix C.1 The Lead Laboratory20c1.pdf [75 KB]
Appendix C.2 Capillary Blood Sampling Protocol5c2.pdf [27 KB]
Appendix C.3 Proficiency Testing and Quality Control
  • Table A. Proficiency Testing Programs for Lead Laboratories
  • Table B. Quality Control Materials for Use in Blood Lead Testing
  • Table C. Quality Control Materials for Use in Urine Lead Testing
  • Table D. Quality Control Materials for Erythorocyte Protoporphyrin Tests.
5c3.pdf [19 KB]

NOTE: To obtain a printed copy of the screening document, please call (toll-free) 800-CDC-INFO (800-232-4636).

Top